* AURIS MEDICAL HOLDING AG – PRELIMINARY TOP-LINE DATA FROM
TACTT3
TRIAL INDICATE THAT STUDY DID NOT MEET ITS PRIMARY EFFICACY
ENDPOINT

Read More At Article Source | Article Attribution